Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy r...
Saved in:
| Published in: | Journal of thrombosis and haemostasis Vol. 18; no. 5; pp. 1094 - 1099 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Limited
01.05.2020
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc |
| Subjects: | |
| ISSN: | 1538-7933, 1538-7836, 1538-7836 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!